• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Comparative analysis of the clinical and epidemiological characteristics of human influenza virus vs. human respiratory syncytial viru

tetano

Editor, Senior Moderator
J Med Virol


. 2022 Aug 18.
doi: 10.1002/jmv.28073. Online ahead of print.
Comparative analysis of the clinical and epidemiological characteristics of human influenza virus vs. human respiratory syncytial virus vs. human metapneumovirus infection in nine provinces of China during 2009-2021


Aili Cui[SUP] 1 [/SUP], Zhibo Xie[SUP] 1 [/SUP], Jing Xu[SUP] 2 [/SUP], Kongxin Hu[SUP] 3 [/SUP], Runan Zhu[SUP] 4 [/SUP], Zhong Li[SUP] 5 [/SUP], Yan Li[SUP] 6 [/SUP], Liwei Sun[SUP] 7 [/SUP], Xingyu Xiang[SUP] 8 [/SUP], Baoping Xu[SUP] 9 [/SUP], Rongbo Zhang[SUP] 10 [/SUP], Zhenguo Gao[SUP] 11 [/SUP], Yan Zhang[SUP] 1 [/SUP], Wenbo Xu[SUP] 1 [/SUP]



Affiliations

Abstract

Background: A comparative analysis of confirmed cases of human influenza virus (HIFV), human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV) was conducted to describe their clinical and epidemiological characteristics.
Methods: During 2009 to 2021, active surveillance of acute respiratory infections (ARIs) was performed in nine provinces of China. Clinical and epidemiological information and laboratory testing results of HIFV, HRSV, and HMPV were analyzed.
Results: Among 11,591 ARI patients, the single-infection rates of HIFV, HRSV, and HMPV were 15.00%, 9.59% and 2.24%, respectively; the coinfection rate of these three viruses was 0.64%. HIFV infection was mainly in adults aged 15-59 years, accounting for 39.10%. HRSV and HMPV infections were mainly in children under 5 years old, accounting for 87.13% and 83.46%, respectively. Patients with HRSV infection were younger than HMPV. HRSV and HMPV had high similarity in clinical manifestations, presenting with lower respiratory symptoms. HIFV mainly presented with upper respiratory infection. The epidemic peak of HRSV was earlier than that of HIFV, and that of HMPV was later than those of HRSV and HFIV. A total of 85.14% of coinfection cases were children under 5 years old. Coinfection might increase the risk of pneumonia in HIFV cases. During 2020-2021, the positive rates and seasonal patterns of these three viruses changed due to the impact of the COVID-19 pandemic.
Conclusions: Certain clinical and epidemiological features were observed in HIFV, HRSV and HMPV infections, which could be benefit for guiding clinical diagnosis, treatment, and prevention of these three viruses in China. This article is protected by copyright. All rights reserved.

Keywords: acute respiratory infection; human influenza; human metapneumovirus; human respiratory syncytial virus.
 
Back
Top Bottom